Nova webinar on COVID-19 bedside glucose management

Create PDF

May 2020—Nova Biomedical announced a webinar, titled “COVID-19 Bedside Glucose Management: Risk of Ascorbic Acid and Hematocrit Interference,” to help inform and support health care workers treating COVID-19 patients. The webinar, led by Charbel Abou-Diwan, PhD, director of Nova Biomedical’s medical and scientific affairs, examines the risk of inaccurate glucose meter results due to interference from ascorbic acid and anemia.

The webinar will be delivered on Thursday, May 28, at 1:00 PM, and Thursday, June 18, at 4:00 PM, Eastern time. Attendees can earn educational credits. Register online at novabiomedical.com/poc/glu/covid.